Effect of Ganoderma on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells

Cancer Letters

Volumn 277, Issue 2, 2009, Pages 182-189

  Sadava, David ^a,b   Still, David W ^c   Mudry, Ryan R ^c   Kane, Susan E ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b KECK GRADUATE INSTITUTE   (United States)

^c CALIFORNIA STATE POLYTECHNIC UNIVERSITY   (United States)

Author keywords

Apoptosis; Chemotherapy; Ganoderma; Lung carcinoma; Multidrug resistance; Sensitization

Indexed keywords

DOXORUBICIN; ETOPOSIDE; GANODERMA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EFFECT; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GANODERMA; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MULTIDRUG RESISTANCE; NICK END LABELING; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CASPASES; CELL LINE, TUMOR; COMPLEX MIXTURES; DNA FRAGMENTATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; ETOPOSIDE; GANODERMA; HUMANS; LUNG NEOPLASMS; SMALL CELL LUNG CARCINOMA;

GANODERMA; GANODERMA LUCIDUM;

EID: 62749176363     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.12.009     Document Type: Article

References (42)

1. Govindan R., Page N., Morgensztern D., Read W., Tierney R., Vhalhiotis A., Spitznagel E., and Piccirillo J. Changing epidemiology of small-cell lung cancer in the US over the past 30 years. J. Clin. Oncol. 24 (2006) 4539-4544
2. In: Pass H.I., Carbone D.P., Johnson D.H., Minna J.D., and Turrisi A.T. (Eds). Lung Cancer Principles and Practice (2005), Lippincott Williams Wilkins, Philadelphia 657-673
3. Nishio W., Nakamura T., Koh Y., Suzuki T., Fukumoto H., and Saijo N. Drug resistance in lung cancer. Curr. Opin. Oncol. 11 (1999) 109-115
4. Gottesman M. Mechanisms of cancer drug resistance. Ann. Rev. Med. 53 (2002) 615-627
5. Hyodo I., Amano N., Eguchi K., Narabayashi M., Imanishi J., Hirai M., Nakano T., and Takashima S. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J. Clin. Oncol. 23 (2005) 2645-2654
6. In: Yuan C.S., Bieber E.J., and Bauer B.A. (Eds). Textbook of Complementary and Alternative Medicine. second ed. (2007), Informa Healthcare/CRC Press, New York
7. Yang C., Chien L.-Y., and Tai C.J. Use of complementary medicine among patients with cancer receiving outpatient chemotherapy. J. Alt. Compl. Med. 14 (2008) 413-416
8. Chan K. Progress to traditional Chinese medicine. Trends Pharm. Sci. 16 (1995) 182-187
9. Huang K.C., and Williams M.W. The Pharmacology of Chinese Herbs (1999), CRC Press, Boca Raton, FL
10. Cohen I., Taglaferri M., and Tripathy D. Traditional Chinese medicine in the treatment of cancer. J. Chin. Med. 68 (2002) 40-55
11. Chang S.T., and Buswell J.A. Ganoderma lucidum (lingzhi), a mushrooming medicinal mushroom. Int. J. Med. Mush. 11 (1999) 1319-1346
12. Sliva D. Ganoderma lucidum in cancer research. Leuk. Res. 30 (2006) 767-768
13. National Audubon Society Field Guide to North American Mushrooms, Knopf, New York, 1993.
14. Zhou Y., Yang X., and Yang Q. Recent advances on triterpenes from Ganoderma mushroom. Food Rev. Internat. 22 (2006) 259-273
15. Upton R. Reishi mushroom, in American Herbal Pharmacopeia (2000), American Herbal Products Association, Silver Spring, MD
16. Paterson R.R. Ganoderma - a therapeutic fungal biofactory. Phytochemistry 67 (2006) 1985-2001
17. Zhu X.L., Chen A.F., and Lin Z.B. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J. Ethnopharm. 111 (2007) 219-226
18. Cao Q.Z., and Lin Z.B. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacol. Sin. 25 (2004) 833-838
19. Gao Y., Zhou S., Jiang W., Huang M., and Dai X. Effects of ganopoly on the immune functions in advanced stage cancer patients. Immunol. Invest. 32 (2003) 201-215
20. Yuen J.W.M., and Gohel M.D. Anticancer effects of Ganoderma lucidum: a review of the scientific evidence. Nutr. Cancer 53 (2005) 11-17
21. Sliva D. Ganoderma lucidum (Reishi) in cancer treatment. Int. Cancer Ther. 2 (2003) 358-364
22. Lin Z.B., and Zhang H.N. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol. Sin. 25 (2004) 1305-1387
23. Lu Q.Y., Sartippour M.R., Brooks M.N., Zhang Q., Hardy M., Go V.L., Li F., and Heber D. Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro. Oncol. Rep. 12 (2004) 659-662
24. Jiang J., Silvova V., Harvey K., Valachovicova T., and Sliva D. Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NFkB signaling. Nutr. Cancer 49 (2004) 209-216
25. Muller C.I., Kumagai T., O'Kelly J., Seeram N., Heber D., and Koeffler H.P. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk. Res. 30 (2006) 841-848
26. Lu Q.Y., Jin Y.S., Zhang Q., Zhang Z., Heber D., Go V.L., Li F.P., and Rao J.Y. Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells. Cancer Lett. 216 (2004) 9-120
27. Hong K.J., Dunn D.M., Shen C.L., and Pence B.C. Effects of Ganoderma lucidum on apoptotic and anti-inflammatory function in HT-29 human colon carcinoma cells. Phytother. Res. 18 (2004) 768-770
28. Stanley G., Harvey K., Silvova V., Jiang J., and Sliva D. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-β1 from prostate cancer cells. Biochem. Biophys. Res. Commun. 330 (2005) 46-52
29. Bonham M., Arnold H., Montgomery B., and Nelson P.S. Molecular effects of the herbal compound PC-SPES: identification of activity pathways on prostate carcinoma. Cancer Res. 62 (2002) 3920-3924
30. Tang W., Liu T.W., Zhao W.M., and Zhong J.J. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in ling cancer cells. Life Sci. 80 (2006) 205-211
31. Li W.D., Zhang B.D., Wei R., Liu J.H., and Lin Z.B. Reversal effect of Ganoderma lucidum polysaccharide on multidrug resistance in K562/ADM cell line. Acta Pharmacol. Sin. 29 (2008) 620-627
32. Hong SG S.G., and Jung H.S. Phylogenetic analysis of Ganoderma based on nearly complete mitochondrial small-subunit ribosomal DNA sequences. Mycologia 96 (2004) 742-755
33. Minato K., Kanzawa F., Nishio K., Nakagawa K., Fujiwara Y., and Saijo N. Characterization of an etoposide-resistant human small-cell lung carcinoma line. Cancer Chemother. Pharmacol. 26 (1990) 313-327
34. Sadava D., Ahn J., Zhan M., Pang M.-L., Ding J., and Kane S.E. Effects of four Chinese herbal extracts on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells. Cancer Chemother. Pharmacol. 49 (2002) 261-266
35. Sadava D., and Hamman W. RNA interference against MDR1 but not MRP1 reverses drug resistance in human small-cell lung cancer cells. J. Cancer Mol. 3 (2007) 91-95
36. E. Hayashi, N. Aoyama, Y. Wu, H.C. Chi, S.J. Boyer, D.W. Still, Multiplexed, quantitative gene expression analysis for lettuce seed germination on GenomeLab GeXP genetic analysis system. , 2007 (accessed 28.09.08).
37. Vandesompele J., Xe D., Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 (2002) 31-34
38. Sturn A., Quackenbush J., and Tranjonski Z. Genesis: cluster analysis of microarray data. Bioinformatics 18 (2002) 207-208
39. Yue G.G.L., Fung K., Tse G.M.L., Leung P.-C., and Lau C.B.S. Comparative studies of various Ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro. J. Alt. Compl. Med. 12 (2006) 777-789
40. Jiang J., Silvova V., Valachovicova T., Harvey K.D., and Sliva D. Ganoderma lucidum inhibits proliferation and induced apoptosis in human prostate cancer cells PC-3. Int. J. Oncol. 24 (2004) 1093-1099
41. Sliva D., Sedlak M., Slivova V., Valachovicova T., Lloyd F., and Ho N. Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J. Alt. Compl. Med. 9 (2003) 491-497
42. Earnshaw W., Martins S., and Kaufmann S. Mammalian caspases: structure, activation, substrates and functions during apoptosis. Ann. Rev. Biochem. 69 (1999) 383-424